ESOMEPRAZOLE SODIUM

Post-LOE

esomeprazole sodium

ANDAINTRAVENOUSINJECTABLE
Approved
Mar 2017
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H/KATPase enzyme system at the secretory surface of the gastric parietal cell. Esomeprazole is protonated and converted in the acidic compartment of the parietal cell forming the active…